top of page

Projects > SIM App Global...

Strategic UX Leadership for Global MedTech: The SIM App Story.

Orchestrated a dual-track strategy to maintain a global legacy platform while architecting a next-generation simulation experience for 6.5K+ users

The SIM App started as a demo tool for the Omnipod 5 App, but evolved into a global platform used by Sales, Clinical Educators, Product Support, and Health Care Providers.

As adoption increased, the product struggled to scale.

Tasked with stabilizing a legacy 3rd-party platform for global launch while simultaneously architecting the future-state redesign.

I led the UX strategy for the Omnipod 5 SIM App, an educational tool for over 6,500 global users. My challenge was twofold: supporting the global rollout of a legacy third-party version while simultaneously leading the ground-up redesign and MVP definition for the future-state platform."

Discovery & Audit

Inheriting a product with significant technical debt required a deep-dive heuristic audit. I reverse-engineered the undocumented architecture to identify localization blockers that were stalling European market entries.

Reverse-Engineering the Legacy Ecosystem.

To protect patient safety, I merged patterns from existing iOS and Android medical apps to create a dedicated 'SIM System.' This ensured that the simulator felt familiar but was visually distinct from the actual medical device, preventing user confusion in high-stakes environments.

Operational Excellence & Delivery Strategy

Developed a roadmap to resolve legacy technical debt while simultaneously aligning future business requirements with validated user needs.

action plan.png

Strategic Action Plan proposal for the operation and maintenance of the 3rd-party version received. 

Archetype-Driven Design

Led the definition of behavioral personas to ensure the simulation met the specific goals of diverse user types, from anxious first-time patients to expert caregivers.

Architype personas@2x.png

i.e. Of Behavioral Archetypes

New Delivery Standard

Moved beyond static specs to a "Unified Source of Truth" in Figma—integrating interactive prototypes, logic annotations, and edge-case scenarios.

One feature multiple scenarios and OS platforms

i.e. Of festure mapping and prototyping for specific scenarios and Operative Systems

This structured hand-off empowered Dev and QA teams to work independently of design bottlenecks, ensuring 100% functional accuracy across all global markets.

Cross-Functional Leadership

I acted as the central strategic link between Development, QA, Localization, and Marketing. By providing 100% testable design logic, I ensured that global releases remained functional across different languages and regulatory requirements

  • Reduced ambiguity in training and demo workflows across sales and clinical teams

  • Accelerated localization and QA validation by prioritizing key scenarios (80/20 approach)

  • Improved cross-team alignment through documented UX flows and annotated deliverables

  • Reduced handoff friction between UX, Development, QA, and Localization teams

Metrics are based on delivery outcomes, process improvements, and cross-team feedback.

MVP Decisions & Outcomes

For the second version the MVP required making deliberate trade-offs between user needs, business priorities, and technical constraints.

The final MVP focused on:
• Core simulation workflows with improved clarity
• Smart Bolus calculation (simulated)
• Alarm scenarios and embedded educational content
• Multi-language and OS switching

This approach enabled:
• A scalable SIM platform for current and future Omnipod products
• Improved clarity and usability for global teams
• Reduced ambiguity for development and QA
• A strong foundation for localization and RTL support

MVP Documentation

Impact

Version 1. Already released

  • Defined the MVP for 16+ core features.

  • Delivered a unified UI library for iOS and Android, unblocking the engineering roadmap for the future-state redesign.

  • 16 Flows for Android delivered and 5 for iOS

Version Two. “New Simulation App”

  • 75% Reduction in Review Cycles.

  • Zero delays in international launch.

  • Reduced QA automation script creation time by ~40% by providing independent functional logic and interaction maps.

Detailed case study, exact metrics, and clinical documentation are available for private walkthrough during interviews to respect NDA and client privacy.

The content of this portfolio cannot be used for any commercial purposes.

Melissa Esquivel 

Portfolio

© 2020 Melissa Esquivel de la Rosa
  • LinkedIn - Melissa Esquivel
  • Instagram - Melesq
bottom of page